You are here
- Home
Crestor (rosuvastatin)
CRESTOR is a member of the statin class; for the treatment of dyslipidaemia. CRESTOR reduces LDL-C (‘bad’ cholesterol) and raises HDL-C (‘good’ cholesterol).CRESTOR was initially developed by the Japanese pharmaceutical company Shionogi and in-licensed to AstraZeneca in April 1998.For rosuvastatin clinical information please visit www.rosuvastatininformation.com
Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.
Links to country-specific websites can be found using the AstraZeneca websites list.
If you still have a question regarding our drug portfolio you can Contact us.
Page tools
Information
This website has been produced in accordance with both the ABPI Code of Practice for the Pharmaceutical Industry 2008 and the EFPIA Code on the Promotion of Prescription-only Medicines to, and interactions with, Healthcare Professionals.